Arch Support Effects on Balance and Gait in Older Adults With Mild Cognitive Impairment
Effects of Arch Support Insoles on Balance and Gait Performance in Older Adults With Mild Cognitive Impairment
1 other identifier
interventional
40
1 country
1
Brief Summary
This study aims to explore the effects of arch support insoles on balance and gait performance in older adults with mild cognitive impairment (MCI). We will recruit 40 female older adults with MCI. A randomized crossover trial will be used to determine the immediate effect of arch support insoles. All participants received one assessment session wearing and one session not wearing insole in a random order within 1-day. Then participants will be randomly allocated to experimental group (arch support insoles, n=20) or control group (no insoles, n=20) for at least 4-h every day for 1-month. Our primary outcomes include static standing balance, timed-up-and-go test, 10-m obstacle crossing, functional reach test, Short Physical Performance Battery (SPPB), and gait assessment during single- and dual-task walking for 20 m at self-selected comfortable pace while performing serial subtractions (cognitive interference) or carrying a tray (motor interference). Assessments will be conducted at baseline and after 2-wk and 4-wk of insole wear. Statistical analyses will be performed using SPSS 21.0 software. Two-way mixed ANOVA will be used to determine the immediate and short- and long-term effect of arch support insoles. The results of the current study are expected to provide evidences in supporting the use of arch support insoles for improving gait performance and postural stability for older adults with MCI which will contribute to balance and gait training as well as fall prevention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2022
CompletedFirst Submitted
Initial submission to the registry
July 19, 2022
CompletedFirst Posted
Study publicly available on registry
July 22, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2022
CompletedJuly 22, 2022
July 1, 2022
6 months
July 19, 2022
July 21, 2022
Conditions
Outcome Measures
Primary Outcomes (6)
Change of static standing balance
30-s static standing balance
at baseline and after 2-wk and 4-wk of insole wear
Change of timed-up-and-go test
3-m timed-up-and-go test
at baseline and after 2-wk and 4-wk of insole wear
Change of 10-m obstacle crossing
10-m obstacle crossing
at baseline and after 2-wk and 4-wk of insole wear
Change of functional reach test
functional reach test
at baseline and after 2-wk and 4-wk of insole wear
Change of Short Physical Performance Battery
Short Physical Performance Battery
at baseline and after 2-wk and 4-wk of insole wear
Change of gait
single- and dual-task walking for 20 m at self-selected comfortable pace while performing serial subtractions (cognitive interference) or carrying a tray (motor interference)
at baseline and after 2-wk and 4-wk of insole wear
Study Arms (2)
experimental group
EXPERIMENTALwear the insoles for at least 4-h every day for 1-month
control group
NO INTERVENTIONnot wear insoles for at least 4-h every day for 1-month
Interventions
The FootDisc insole is designed with curEVA for shock absorption and motion reduction, poron for secondary heel and metatarsal protection, and dynamic arch support for returning energy for propulsion
Eligibility Criteria
You may qualify if:
- (1) female aged 65 years and over; (2) able to walk more than 20 m without walking aids; (3) had a Montreal Cognitive Assessment (MoCA) score lower than 26 ; (4) had self-reported memory complaints; and (5) had the ability to perform ADLs.
You may not qualify if:
- (1) dementia; (2) a history of malignant tumors ; (3) the presence of an unstable neurological or orthopedic disease, or visual problems interfering with participation in the study; and (4) an education level less than 6 years (elementary school).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cardinal Tien Hospital
New Taipei City, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Chen-Yi Song
National Taipei University of Nursing and Health Sciences
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate professor
Study Record Dates
First Submitted
July 19, 2022
First Posted
July 22, 2022
Study Start
July 1, 2022
Primary Completion
December 31, 2022
Study Completion
December 31, 2022
Last Updated
July 22, 2022
Record last verified: 2022-07